Hillsdale Investment Management’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-30
| Closed | -$12K | – | 621 |
|
|
2022
Q1 | $12K | Hold |
30
| – | – | ﹤0.01% | 523 |
|
|
2021
Q4 | $14K | Hold |
30
| – | – | ﹤0.01% | 537 |
|
|
2021
Q3 | $13K | Hold |
30
| – | – | ﹤0.01% | 526 |
|
|
2021
Q2 | $11K | Sell |
30
-1,780
| -98% | -$653K | ﹤0.01% | 538 |
|
|
2021
Q1 | $509K | Sell |
1,810
-50
| -3% | -$14.1K | 0.04% | 360 |
|
|
2020
Q4 | $526K | Buy |
1,860
+30
| +2% | +$8.48K | 0.05% | 340 |
|
|
2020
Q3 | $502K | Buy |
+1,830
| New | +$502K | 0.05% | 319 |
|
|
2019
Q4 | – | Sell |
-3,300
| Closed | -$468K | – | 671 |
|
|
2019
Q3 | $468K | Buy |
+3,300
| New | +$468K | 0.04% | 367 |
|
|
2018
Q1 | – | Sell |
-80
| Closed | -$8K | – | 539 |
|
|
2017
Q4 | $8K | Sell |
80
-12,000
| -99% | -$1.2M | ﹤0.01% | 373 |
|
|
2017
Q3 | $1.16M | Hold |
12,080
| – | – | 0.2% | 114 |
|
|
2017
Q2 | $1.14M | Buy |
12,080
+80
| +0.7% | +$7.56K | 0.22% | 85 |
|
|
2017
Q1 | $979K | Hold |
12,000
| – | – | 0.19% | 112 |
|
|
2016
Q4 | $1.02M | Buy |
12,000
+2,200
| +22% | +$187K | 0.21% | 112 |
|
|
2016
Q3 | $730K | Buy |
9,800
+3,500
| +56% | +$261K | 0.19% | 77 |
|
|
2016
Q2 | $478K | Hold |
6,300
| – | – | 0.14% | 101 |
|
|
2016
Q1 | $437K | Buy |
+6,300
| New | +$437K | 0.15% | 117 |
|
|
2014
Q4 | – | Sell |
-100
| Closed | -$4K | – | 598 |
|
|
2014
Q3 | $4K | Hold |
100
| – | – | ﹤0.01% | 532 |
|
|
2014
Q2 | $4K | Hold |
100
| – | – | ﹤0.01% | 532 |
|
|
2014
Q1 | $4K | Hold |
100
| – | – | ﹤0.01% | 525 |
|
|
2013
Q4 | $5K | Sell |
100
-100
| -50% | -$5K | ﹤0.01% | 517 |
|
|
2013
Q3 | $8K | Buy |
+200
| New | +$8K | ﹤0.01% | 477 |
|